The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration
Abstract
Lysergic acid diethylamide (LSD) is a psychoactive drug that transiently alters human perception, behavior, and mood at extremely low doses. Certain aspects of the behavior elicited by acute doses of LSD closely resemble symptoms of mental disorders such as schizophrenia. Characterizing gene expression profiles after LSD will be important for understanding how it alters behavior, and will lead to novel insights into disorders, such as schizophrenia, whose behavioral symptoms resemble the temporary effects of hallucinogenic drugs. We previously identified a small collection of genes within the rat prefrontal cortex that respond to LSD. Many of the products of these genes are involved in the process of synaptic plasticity. In the current report, we present a detailed analysis of the expression of these genes within the brain using RNase protection analysis. We find that the gene response to LSD is quite dynamic. The expression of some genes increases rapidly and decreases rapidly, while other genes change more gradually. Dose-response studies show two classes of expression; gene expression maximally stimulated at lower doses, versus gene expression that continues to rise at the higher doses. The role of the 5-HT(1A) and 5-HT(2A) receptor in mediating the increases in gene expression was examined in a series of experiments using receptor specific antagonists. Most expression increases were due to activation of the 5-HT(2A) receptor, however expression of two genes had neither a…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Findings from in vivo studies investigating acute effects of a single dose of 5-MeO-DMT, DMT, psilocybin, and LSD (37%) suggest altered cellular plasticity of structural and functional nature (54–60).”
From Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. (2021) · cites this paper as [58]
In the citing paper
“A single dose of LSD (0.20, 0.24, 0.5, 1.0 mg/kg i.p.) stimulated the mRNA expression of plasticity-promoting genes in the cortex of rats and mice, within 1–2 h after administration and in a time- and dose-dependent manner (56–59).”
From Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics. (2021) · cites this paper as [58]
In the citing paper
“preclinical evidence suggests a dose-dependent effect on increases in the expression of some neuroplasticity-related genes induced by serotonergic psychedelics [73–75]”
Citations
Cites
Roles of Nuclear Factor κB in Neuronal Survival and Plasticity
Mattson, M. P., Culmsee, C., Yu, Z., & Camandola, S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740443.x · Cited by 457
Vollenweider, F. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00246-1 · Cited by 444
Aghajanian, G. K., & Marek, G. J. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01224-x · Cited by 374
Aghajanian, G. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00135-3 · Cited by 371
Titeler, M., Lyon, R. A., & Glennon, R. A. (1988) · Psychopharmacology · doi:10.1007/bf00176847 · Cited by 343
Le Bail, O., Schmidt-Ullrich, R., & Israël, A. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06197.x · Cited by 323
Kennett, G. A., Wood, M. D., Bright, F., Cilia, J., Piper, D. C., Gager, T., Thomas, D., Baxter, G. S., Forbes, I. T., Ham, P., et al. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15208.x · Cited by 240
Bottai, D., Guzowski, J. F., Schwarz, M. K., Kang, S. H., Xiao, B., Lanahan, A., Worley, P. F., & Seeburg, P. H. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00167.2002 · Cited by 217
Serotonergic basis of antipsychotic drug effects in schizophrenia
Lieberman, J. A., Mailman, R. B., Duncan, G., Sikich, L., Chakos, M., Nichols, D. E., & Kraus, J. E. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00187-5 · Cited by 206
Aghajanian, G., & Marek, G. (1999) · Neuropsychopharmacology · doi:10.1038/sj.npp.1395318 · Cited by 198
Cited by
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
Nichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211
Nichols, D. E., & Nichols, C. D. (2008) · Chemical Reviews · doi:10.1021/cr078224o · Cited by 895
Self-citationThe pharmacology of lysergic acid diethylamide: A review
Passie, T., Halpern, J. H., Stichtenoth, D. O., Emrich, H. M., & Hintzen, A. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00059.x · Cited by 455
Serotonin and brain development
Sodhi, M. S. K., & Sanders-Bush, E. (2004) · International Review of Neurobiology · doi:10.1016/s0074-7742(04)59006-2 · Cited by 340
Self-citation
Metadata
- Authors
- Nichols, C. D., Garcia, E. E., & Sanders-Bush, E.
- Affiliations
- Vanderbilt University (US)
- Corresponding author
- Nichols, Charles D.
- ORCID
- Nichols, Charles D.
- Venue
- Molecular Brain Research
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 111
- Issue
- 1-2
- Pages
- 182-188
- ISSN
- 0169-328X (ISSN-L)
- OpenAlex
- W1991128922
- Semantic Scholar
- 4444f5b8d82445ed24853bc17903681a3174b10a
- Cited by
- 82
- References
- 25
- Citations by year
- 2025: 5 · 2024: 7 · 2023: 5 · 2022: 5 · 2021: 12 · 2020: 5 · 2019: 1 · 2018: 4 · 2017: 4 · 2016: 2 · 2015: 2 · 2014: 2 · 2013: 3 · 2012: 1
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Molecular Brain Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (DA-05181, DA 05993, R01DA005181, F32DA005993)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- lysergic acid diethylamide, LSD, prefrontal cortex, gene expression, hallucinogens, synaptic plasticity, 5-HT2A receptor, 5-HT1A receptor, receptor antagonists, dose-response relationship, schizophrenia
- MeSH terms
- Homer Scaffolding Proteins, Animals, Carrier Proteins, Dose-Response Relationship, Drug, Gene Expression Regulation, Hallucinogens, Lysergic Acid Diethylamide, Male, Nerve Tissue Proteins, Synaptic Transmission, Neuronal Plasticity, Neurons, Neuropeptides, Reaction Time, Receptors, Serotonin, RNA, Schizophrenia, Serotonin, Serotonin Antagonists, Up-Regulation, NF-kappa B, Rats, Sprague-Dawley, Prefrontal Cortex, Genes, Immediate-Early, Receptors, Serotonin, 5-HT1, Receptor, Serotonin, 5-HT2A, Rats, Transcription Factor RelA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration. https://app.cochat.ai/papers/10.1016/s0169-328x(03)00029-9
- The paper
- Nichols, C. D., Garcia, E. E., & Sanders-Bush, E. (2003). Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration. Molecular Brain Research. https://doi.org/10.1016/s0169-328x(03)00029-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.